Grandfield & Dodd’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Other funds holding IOVA
Grandfield & Dodd's IOVA Position: Q3 2026 in Review
Grandfield & Dodd reduced its Iovance Biotherapeutics (IOVA) stake by 0.03% in Q3 2026, selling an estimated $143 and leaving 62,500 shares worth $926K. The position accounts for 0.05% of the portfolio, ranked #117.
Grandfield & Dodd first reported a position in IOVA in Q3 2024 and has held it in 9 quarters since. 334 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.
- Grandfield & Dodd held 62,500 shares of Iovance Biotherapeutics worth $926K as of Q3 2026.
- Grandfield & Dodd sold 20 Iovance Biotherapeutics shares in Q3 2026, an estimated $143.
- Iovance Biotherapeutics made up 0.05% of Grandfield & Dodd's portfolio in Q3 2026, its #117 holding.
- Grandfield & Dodd first reported a position in Iovance Biotherapeutics in Q3 2024 and has held it in 9 quarters since.
- 334 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.
Based on Grandfield & Dodd's 13F filing for Q3 2026, filed 29 Oct 2026.